04.07.2024

Affini-T Therapeutics Presents Preclinical Data from its Oncogenic Driver Programs Targeting KRAS G12D and p53 R175H at the American Association for Cancer Research (AACR) Annual Meeting 2024

Press Releases

03.13.2024

Affini-T Therapeutics to Present Preclinical Data from its Programs Targeting KRAS G12D and p53 R175H and Two Trials in Progress at the American Association for Cancer Research (AACR) Annual Meeting

Press Releases

01.07.2024

Affini-T Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Press Releases

ENDPOINTS

06.02.2023

Exclusive: Affini-T taps Sanofi alum to lead hunt for partnerships; Alkermes locks in CEO for oncology spinout

News

ENDPOINTS

04.19.2023

KRAS, one of cancer’s toughest targets, sees a surge of new therapies trying to limit side effects: #AACR23

News

ENDPOINTS

11.28.2022

Endpoints’ 10 biggest stories of 2022

News

04.07.2024

American Association for Cancer Research (AACR) Annual Meeting 2024, Poster #10

Presentations

04.07.2024

American Association for Cancer Research (AACR) Annual Meeting 2024, Poster #9

Presentations

11.03.2023

Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting 2023, Poster #1233

Presentations